BRVE
Current: $20.77 as of 2026-11-03T00:30:03.050Z · 2025-11-08 → 2026-11-08
All trades in BRVE
Lubner David Charles Director
bought BRVE
at $18.00
on 2026-08-07
· return since +15.4%
(now $20.77)
Murdoch Travis CEO and President
bought BRVE
at $18.00
on 2026-08-07
· return since +15.4%
(now $20.77)
Anderson Michele A. Chief Development Officer
bought BRVE
at $18.00
on 2026-08-07
· return since +15.4%
(now $20.77)
Viehbacher Christopher Director
bought BRVE
at $18.00
on 2026-08-07
· return since +15.4%
(now $20.77)
Rickey James Paul Chief Financial Officer
bought BRVE
at $18.00
on 2026-08-07
· return since +15.4%
(now $20.77)
Forbion Growth Opportunities Fund III Cooperatief U.A. 10% Owner
bought BRVE
at $18.00
on 2026-08-07
· return since +15.4%
(now $20.77)
Forbion Growth Opportunities Fund III Cooperatief U.A. 10% Owner
bought BRVE
at $18.00
on 2026-08-07
· return since +15.4%
(now $20.77)
OrbiMed Genesis GP LLC Director, 10% Owner
bought BRVE
at $18.00
on 2026-08-07
· return since +15.4%
(now $20.77)
OrbiMed Genesis GP LLC Director, 10% Owner
bought BRVE
at $18.00
on 2026-08-07
· return since +15.4%
(now $20.77)
Chimovits Erez Director, 10% Owner
bought BRVE
at $18.00
on 2026-08-07
· return since +15.4%
(now $20.77)
Chimovits Erez Director, 10% Owner
bought BRVE
at $18.00
on 2026-08-07
· return since +15.4%
(now $20.77)
Rickey James Paul Chief Financial Officer
bought BRVE
at $18.00
on 2026-08-07
· return since +15.4%
(now $20.77)
Viehbacher Christopher Director
bought BRVE
at $18.00
on 2026-08-07
· return since +15.4%
(now $20.77)
Murdoch Travis CEO and President
bought BRVE
at $18.00
on 2026-08-07
· return since +15.4%
(now $20.77)
Lubner David Charles Director
bought BRVE
at $18.00
on 2026-08-07
· return since +15.4%
(now $20.77)
Forbion Growth Opportunities Fund III Cooperatief U.A. 10% Owner
bought BRVE
at $18.00
on 2026-08-07
· return since +15.4%
(now $20.77)
Forbion Growth Opportunities Fund III Cooperatief U.A. 10% Owner
bought BRVE
at $18.00
on 2026-08-07
· return since +15.4%
(now $20.77)
Anderson Michele A. Chief Development Officer
bought BRVE
at $18.00
on 2026-08-07
· return since +15.4%
(now $20.77)
Chimovits Erez Director, 10% Owner
bought BRVE
at $18.00
on 2026-08-07
· return since +15.4%
(now $20.77)
Chimovits Erez Director, 10% Owner
bought BRVE
at $18.00
on 2026-08-07
· return since +15.4%
(now $20.77)
ORBIMED ADVISORS LLC Director, 10% Owner
bought BRVE
at $18.00
on 2026-08-07
· return since +15.4%
(now $20.77)
ORBIMED ADVISORS LLC Director, 10% Owner
bought BRVE
at $18.00
on 2026-08-07
· return since +15.4%
(now $20.77)
AH Bio Fund IV, L.P. 10% Owner
bought BRVE
at $18.00
on 2026-08-07
· return since +15.4%
(now $20.77)